Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 13/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | KDM6B | O15054 | 1/20 | 0.34 |
| ▸ | KDM4A | O75164 | 1/20 | 0.34 |
| ▸ | KDM5C | P41229 | 1/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.34 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.34 |
| ▸ | KDM3A | Q9Y4C1 | 1/20 | 0.34 |
| ▸ | TGFBR1 | P36897 | 3/20 | 0.32 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.32 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24626925 | 0.83 | KDM4E (0.37) | KDM4EKDM6BKDM4AKDM5CKDM4C | |
| SCHEMBL24627025 | 0.81 | GRM5 (0.44) | GRM5KDM4EKDM6BKDM4AKDM5C | |
| SCHEMBL24627008 | 0.79 | KDM4E (0.34) | KDM4EKDM6BKDM4AKDM5CKDM4C | |
| SCHEMBL22114508 | 0.78 | KAT6A (0.35) | GRM5KDM4EPIK3CAPIK3CBPIK3CG | |
| SCHEMBL24626542 | 0.78 | KDM4E (0.45) | GRM5KDM4EKDM6BKDM4AKDM5C | |
| SCHEMBL23081963 | 0.77 | KDM4E (0.44) | GRM5KDM4EKDM6BKDM4AKDM5C | |
| SCHEMBL24626209 | 0.77 | KDM4E (0.44) | GRM5KDM4EKDM6BKDM4AKDM5C | |
| SCHEMBL24627020 | 0.76 | KDM4E (0.46) | GRM5KDM4EKDM6BKDM4AKDM5C | |
| SCHEMBL23081840 | 0.76 | RAB9A (0.44) | GRM5KDM4EKDM6BKDM4AKDM5C | |
| SCHEMBL24626538 | 0.75 | TGFBR1 (0.44) | GRM5KDM4EKDM6BKDM4AKDM5C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220223795-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2022-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220223795-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | CRY1, CYP1A1, CYP1B1 | GRM5 3413/4885KDM4E 2496/4885KDM6B 1484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.